Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

From bottleneck to breakthrough: Why AI is crucial for progress in healthcare and pharma

Rising costs, a shortage of specialists and a flood of data are pushing the healthcare system and the pharmaceutical industry to their limits. Why artificial intelligence is now the key to taking care, research and development to a new level.

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Article

A Deep Dive into Tabular In-Context Learning

ICL Models vs. Boosting for Tabular Data, Where New Transformer Approaches Excel and Where Traditional ML Methods Still Dominate.

Article

AI is now part of our culture. Communities will determine what comes next

How AI is transforming our society, and why it is not technology alone, but communities, values, and responsibility that will determine the future we shape with AI.

Article

Harnessing the Potential of AI in Manufacturing: A Consortium Approach

Bridging the gap between AI potential and measurable impact on the shop floor

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.